U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539181) titled 'Disclosing Agents as Photosensitizers in aPDT for Biofilm Control in Children' on April 07.
Brief Summary: This randomized controlled clinical trial aims to evaluate the effectiveness of plaque disclosing agents used as photosensitizers in antimicrobial photodynamic therapy (aPDT) for the control of dental biofilm in children aged 3 to 7 years. Participants will be allocated into groups to receive different treatment protocols, and biofilm levels will be assessed before and after the interventions. The primary outcome is the reduction of dental biofilm, aiming to determine whether disclosing agents can be an effective alternative p...